Skip to content

Tailored PCA Based on Preoperative Pain Sensitivity

The Effectiveness of Tailored Patient Controlled Analgesia Based on Preoperative Pain Sensitivity in Gynecological Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03252977
Enrollment
118
Registered
2017-08-17
Start date
2017-08-21
Completion date
2017-11-24
Last updated
2018-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Patient-Controlled

Keywords

fentanyl, Pain Threshold, predicted

Brief summary

Opioids via intravenous patient-controlled analgesia (IV PCA) are widely used for postoperative pain control. However, effective pain control with minimized side effects of analgesic agents is still challenging. Several studies reported that preoperative pain sensitivity measured by quantitative sensory test could predict postoperative pain. Therefore, the investigators planned this trial to evaluate the effectiveness of tailored patient-controlled analgesia based on preoperative pain sensitivity measured by pressure pain threshold in patients undergoing gynecological surgery.

Interventions

OTHERTailored regimen of IV PCA according to pain sensitivity

In tailored group, fentanyl dosage in IV PCA will be determined according to preoperative pain sensitivity. In control, group, fentanyl dosage in IV PCA will be determined without consideration of patient's pain sensitivity.

OTHERRegimen of IV PCA without considering pain sensitivity

In control group, regimen of IV PCA will be determined without consideration about patient's pain sensitivity.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients scheduled to undergo elective gynecological surgery under general anesthesia * patients scheduled to use IV PCA for postoperative analgesia * patients with American Society of Anesthesiologists (ASA) physical status classification I, II, III

Exclusion criteria

* contraindication to fentanyl use * inability to communication * age less than 18 years, or more than 80 years * body weight less than 40kg, or more than 90kg * morbid cardiovascular disease * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
postoperative nauseaduring the postoperative 3 daysIncidence of postoperative nausea

Secondary

MeasureTime frameDescription
incidence of postoperative vomitingduring the postoperative 3 daysincidence of postoperative vomiting
Severity of postoperative nauseaduring the postoperative 3 daysnumeric rating scale
Incidence of other postoperative adverse effectsduring the postoperative 3 daysitching sense, urinary retention, drowsiness, dry mouth, sweating, respiratory depression
cumulative dose of drug that infused via IV PCAduring the postoperative 3 dayscumulative dose of drug that infused via IV PCA
postoperative pain scoresduring the postoperative 3 daysnumeric rating scale
rescue analgesicsduring the postoperative 3 daysamount of administered rescue analgesics
antiemetic agentsduring the postoperative 3 daysamount of administered antiemetic agents
satisfaction scoreduring the postoperative 3 daysPatient's satisfaction with postoperative analgesia (0:totally unsatisfied and 100: totally satisfied)
Incidence of IV PCA clampingduring the postoperative 3 daysIncidence of IV PCA clamping

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026